Mayo Clinic completes first genome-wide analysis of peripheral T-cell... ( ROCHESTER Minn.-- Researchers at May...)

Mayo Clinic completes first genome-wide analysis of peripheral T-cell lymphomas

Date:8/1/2012

ROCHESTER, Minn.-- Researchers at Mayo Clinic have completed the world's first genome-wide sequencing analysis of peripheral T-cell lymphomas, unlocking the genetic secrets of this poorly understood and highly aggressive cancer of the immune system.

Andrew Feldman, M.D., a Mayo Clinic pathologist and Damon Runyon Clinical Investigator, and a team of researchers affiliated with Mayo's Center for Individualized Medicine and Mayo Clinic Cancer Center, found 13 genomic abnormalities that were seen in multiple peripheral T-cell lymphomas. Of particular interest, five of these abnormalities relate to production and behavior of the p53 protein -- often called the "guardian of the genome" because of the central role it plays in regulating cell life cycles and, therefore, suppressing cancers.

The study, entitled "Genome-wide Analysis Reveals Recurrent Structural Abnormalities of TP63 and other p53-related Genes in Peripheral T-cell Lymphomas," is scheduled for early release in the online edition of the journal Blood at 9 a.m. on Wednesday, Aug. 1, 2012.

"Every time I diagnose a peripheral T-cell lymphoma, I know that two out of three patients will succumb to that lymphoma," says Dr. Feldman. "That's a very unsatisfying feeling, and I hope that our research can help change those statistics."

Peripheral T-cell lymphomas account for about 12 percent of non-Hodgkin's lymphomas and carry remarkably high mortality rates. Fewer than 35 percent of patients live five years beyond diagnosis.

New diagnostic biomarkers (chemical or genetic clues in the body's system) and treatments aimed at specific subgroups of peripheral T-cell lymphomas could lead to improved outcomes, says Dr. Feldman. Developing these, however, has been a challenge for several reasons. Lymphomas that look remarkably similar under a microscope may differ substantially in their overall prognoses and responses to treatment. Additionally, scientists and doctors h
'/>"/>

Contact: Sam Smith
newsbureau@mayo.edu
507-284-5005
Mayo Clinic
Source:Eurekalert

0

GOOD

Page: 1 2
Related medicine news :

1. Lower GI problems plague many with rheumatoid arthritis, Mayo Clinic study finds
2. First targeted nanomedicine to enter human clinical studies
3. Clinical insight improves treatment with new lung cancer drug
4. Clinical news alert from the American Academy of Orthopaedic Surgeons
5. Mayo Clinic launches whole genome breast cancer study
6. Mayo Clinic offers newly approved treatment for acid reflux disease
7. NYU Langone experts present research, clinical advances at neurosurgeons meeting
8. Mayo Clinic breast cancer study finds new type of mutation
9. Kroenke honored for outstanding contributions in clinical research training
10. Awards celebrate clinical research that can improve health and alleviate suffering
11. Association for Psychological Science, SAGE launch Clinical Psychological Science

Post Your Comments:

(Date:5/24/2013)... A recent study by research group Harris Interactive found ... suit season. Almost 138 million people are fearful of pulling ... weight issues and a quarter admit they feel pressured to ... that those anxious about their size consider the over the ... overall effort to improve diet and exercise habits ahead of ...

(Date:5/24/2013)... Compromise is often cited as crucial for ... to sleep and comfort. However, many couples find themselves facing ... some, this can cause added stress, lost sleep, and some ... eight common issues in their latest article on the subject. ... Firm: What to do When You Disagree on the Best ...

(Date:5/24/2013)... 24, 2013 DePuy ASR lawsuit ... continue to move forward in courts throughout the country, ... in California’s San Francisco Superior Court on April 25th, ... of her DePuy hip lawsuit is voluntarily seeking dismissal ... et al., No. CGC11508806; Calif. Super. Ct., San Francisco). ...

(Date:5/24/2013)... 2013 KC and Monica Craichy, Founders of ... FreeRide836. Their oldest sons, Kyle and Austin Craichy, will be ... and several professional kiteboarders. , KC Craichy said he is ... miraculously come together such that virtually everyone who planned to ... 20 kite boarders will meet at Matheson Hammock Park and ...

(Date:5/24/2013)... 24, 2013 CHI-California Healthcare Institute ... the California congressional delegation, joined by over 40 ... user fees paid to the U.S. Food and ... future across-the-board cuts will not include user fees ... Agriculture, Rural Development and FDA Appropriations Bill. CHI ...

Breaking Medicine News(10 mins):Health News:PhenObestin 37.5 Can Help Make Bathing Suit Season Less Stressful 2 Health News:PhenObestin 37.5 Can Help Make Bathing Suit Season Less Stressful 3 Health News:What’s The Best Bed Offers Mattress & Sleep Solutions for Opposite Couples 2 Health News:DePuy ASR Hip Lawsuit News: Bernstein Liebhard LLP Notes Request for Voluntary Dismissal in California DePuy Hip Recall Case 2 Health News:DePuy ASR Hip Lawsuit News: Bernstein Liebhard LLP Notes Request for Voluntary Dismissal in California DePuy Hip Recall Case 3 Health News:DePuy ASR Hip Lawsuit News: Bernstein Liebhard LLP Notes Request for Voluntary Dismissal in California DePuy Hip Recall Case 4 Health News:FreeRide836 Sponsor Living Fuel, The Leader in Superfood Nutrition, Announces Kiteboard Launch For This Sunday To Raise Money For Orphans In Africa 2 Health News:FreeRide836 Sponsor Living Fuel, The Leader in Superfood Nutrition, Announces Kiteboard Launch For This Sunday To Raise Money For Orphans In Africa 3 Health News:California Biomedical Industry Leaders Urge Congress to Take Action on FDA User Fees for FY2014 2 Health News:California Biomedical Industry Leaders Urge Congress to Take Action on FDA User Fees for FY2014 3

[0] PhenObestin 37.5 Can Help Make Bathing Suit Season Less Stressful [0] What’s The Best Bed Offers Mattress & Sleep Solutions for Opposite Couples [0] DePuy ASR Hip Lawsuit News: Bernstein Liebhard LLP Notes Request for Voluntary Dismissal in California DePuy Hip Recall Case [0] FreeRide836 Sponsor Living Fuel, The Leader in Superfood Nutrition, Announces Kiteboard Launch For This Sunday To Raise Money For Orphans In Africa [0] California Biomedical Industry Leaders Urge Congress to Take Action on FDA User Fees for FY2014

... , , , ... Aug. 18 Cardinal Health today reported fiscal 2009 diluted earnings per ... basis(1), which was in line with the company,s expectations and includes a ... manufacturing business as discontinued operations. , , The ...

... , ... HemCon Medical Technologies, Inc. today announced that ... two products added to the Hemostasis Products category with Premier Purchasing ... is effective August 1, 2009 through Oct 1, 2011. The agreement ...

... ... , ... 18, 2009 -- Inc. magazine recently included Enovate in its annual Inc. 5000 ... revenue growth from the last four years, is a comprehensive look at one of the ...

... ... Specialists, Avisena, Announces Increased Earnings for the Second Quarter, Including Positive Operating Profit for ... ... company servicing the health care industry that offers a proprietary, Internet-based technology platform, announced ...

... , , , ... Plans (CDHPs) in the U.S. have surpassed HMO plans in covered ... from its 2009 UBA Health Pl a ... with 17,655 plans from 12,316 employers reporting. , , ...

... 17 Attendance on Demand employee time and attendance service ... 5 Tools to Control Labor Costs" Wednesday, August 26 -- ... ebinar/index.html , , The ... cost of labor, the most significant expense faced by the ...

Cardinal Health Reports Fiscal 2009 Results, Provides Fiscal 2010 Outlook Hemostatic HemCon Dressings Selected by the Premier Healthcare Alliance for Hemostasis Products Contract Inc. Magazine Names Enovate as One of the Fastest-Growing Private Companies in the US.Avisena Announces Major Increases in Profit for Second Quarter 2009 Consumer Driven Health Plans Surpass HMOs in Popularity With Employees Attendance on Demand, Inc. Hosts Free Webinar 'Top 5 Tools to Control Labor Costs' for Long-Term Healthcare Professionals 2:30pm EDT August 26, 2009

(Date:5/24/2013)... and BOSTON , May 24, 2013 ... company, is pleased to announce that it has engaged Mr ... Company,s business development capabilities in Japan and ... years of experience in business development, licensing and alliance management in ... Pharma ( Japan ), Nippon Roche and Tanabe Seiyaku ...

(Date:5/23/2013)... PARÍS, 24 de mayo de 2013 Volcano ... desarrollador y fabricante de herramientas de precisión para ... tratamiento de la enfermedad vascular periférica y coronaria, ... ( Ad enosine V asodilator I ... durante la sesión de ensayo clínico hot line ...

(Date:5/23/2013)... , May 23, 2013 Haemonetics Corporation (NYSE: ... , CFO & EVP-Business Development, will present at The Deutsche ... Boston, MA on May 29, 2013 ... ) The public may access Mr. Lindop,s ... About Haemonetics Haemonetics (NYSE: HAE ...

Breaking Medicine Technology:Heptares Augments Business Development Capabilities in Japan and Other Asian Territories 2 Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 2 Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 3 Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 4 Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 5 Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 6

[0] Heptares Augments Business Development Capabilities in Japan and Other Asian Territories [0] Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 [0] Haemonetics to Present at The Deutsche Bank 38th Annual dbAccess Health Care Conference

... Inc. (NASDAQ: ELGX ), developer and marketer of ... the three and six months ended June 30, 2011. ... "We are pleased with our progress during the quarter and ... development goals for 2011. In the second quarter, global revenue ...

... MedSolutions , a leading provider ... its Lumbar Spine Surgery Management Program for ensuring the ... lower back pain, spinal stenosis, spondylolisthesis, scoliosis, trauma, infections ... been estimated that up to 80 percent of the ...

Cached Medicine Technology:Endologix Reports 22% Second Quarter 2011 Revenue Growth 2 Endologix Reports 22% Second Quarter 2011 Revenue Growth 3 Endologix Reports 22% Second Quarter 2011 Revenue Growth 4 Endologix Reports 22% Second Quarter 2011 Revenue Growth 5 Endologix Reports 22% Second Quarter 2011 Revenue Growth 6 Endologix Reports 22% Second Quarter 2011 Revenue Growth 7 Endologix Reports 22% Second Quarter 2011 Revenue Growth 8 Endologix Reports 22% Second Quarter 2011 Revenue Growth 9 MedSolutions Introduces Spine Surgery Management Program 2 MedSolutions Introduces Spine Surgery Management Program 3

Endologix Reports 22% Second Quarter 2011 Revenue Growth MedSolutions Introduces Spine Surgery Management Program

... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...

... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...

... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...

Medicine Products:

Arylsulfatase A, Urine Arthropod Identification Arsenic, Tissue Arsenic, Nails